Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2015 / Apr / Stop the Press!
Training and education Profession Professional Development

Stop the Press!

04/27/2015 1 min read

Share

Last month, JAMA published a paper that created waves. The study – “Diagnostic concordance among pathologists interpreting breast biopsy specimens,”(1) – cites its primary objective as quantifying “the magnitude of diagnostic disagreement among pathologists compared with a consensus panel.” If you get the sneaking suspicion that the outcome was unlikely to be positive, you’re not wrong; disagreement was reported in around 25 percent of cases.Unsurprisingly, discordance was highest in those cases deemed as “borderline” diagnoses of atypical hyperplasia and DCIS. Though the results are pretty damning on the face of it, the lack of commonality between the study methodology and real-life conditions was not given sufficient attention. For example, the pathologists who took part were unable to solicit a second opinion; not only is that commonly practiced, it’s expected.

Nonetheless, the story was inevitably spread via many media channels in the medical profession and beyond. Even more worryingly, there have also been reports on the dwindling number of women attending breast cancer screening in some countries; better education on the risk of misdiagnosis being cited as a factor. It is clear that pathology is gaining a bad reputation from some of this publicity – unjustifiably. We talk regularly of the need for pathologists to communicate with those outside of their profession and to educate on the value of pathology. Sadly, most consumer attention tends to be generated when things apparently “go wrong”. The press will always pick up on the most impactful and newsworthy element of a piece of research. And let‘s face it, pathologists disagreeing on diagnoses is a pretty shocking and saleable story. But perhaps this situation can be flipped on its head and used to pathologists’ advantage. Why not get out there and talk about your role, in particular its criticality to a patient’s health, and defend against some of the research that has negatively represented pathology to the public and your medical peers? In response to the JAMA piece, we did our own digging around and bring you the story from different perspectives in this month’s cover feature. Don’t let negative comments go unanswered on Twitter, Facebook or LinkedIn - better still, write a blog about the bias introduced by reporters and link to as many sources as possible. In other words: take control.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. JG Elmore, et al., “Diagnostic concordance among pathologists interpreting breast biopsy specimens”, JAMA, 313, 1122–1132 (2015). PMID: 25781441.

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

The Transformative Power of Patient Advocacy
Training and education
The Transformative Power of Patient Advocacy

January 24, 2024

3 min read

Michele Mitchell shares her personal journey into patient advocacy

Navigating Digital Scholarship and Professional Growth
Training and education
Navigating Digital Scholarship and Professional Growth

January 16, 2024

5 min read

How can new-in-practice pathologists leverage the power of social media to enhance traditional academic work?

Life Balance
Training and education
Life Balance

January 5, 2024

9 min read

Sitting Down With… Kamran Mirza, Professor of Pathology and Director of the Division of Education Programs, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, United States

An Identity in Danger
Training and education
An Identity in Danger

January 4, 2022

1 min read

Pathology doesn’t just need a place in medical school curricula – it needs to be prepared to take advantage of that place

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.